293 related articles for article (PubMed ID: 23812967)
1. Understanding clinic options for overactive bladder.
Bartley JM; Blum ES; Sirls LT; Peters KM
Curr Urol Rep; 2013 Dec; 14(6):541-8. PubMed ID: 23812967
[TBL] [Abstract][Full Text] [Related]
2. Overactive bladder syndrome - management and treatment options.
Arnold J; McLeod N; Thani-Gasalam R; Rashid P
Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
[TBL] [Abstract][Full Text] [Related]
3. Optimizing Nonsurgical Treatments of Overactive Bladder in the United States.
Brucker BM; Lee RK; Newman DK
Urology; 2020 Nov; 145():52-59. PubMed ID: 32598892
[TBL] [Abstract][Full Text] [Related]
4. Treatment of overactive bladder symptoms beyond antimuscarinics: current and future therapies.
Ellsworth P
Postgrad Med; 2012 May; 124(3):16-27. PubMed ID: 22691895
[TBL] [Abstract][Full Text] [Related]
5. An overview of treatment of overactive bladder syndrome in women.
Allahdin S; Oo N
J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
[TBL] [Abstract][Full Text] [Related]
6. [Second-line therapy of idiopathic detrusor overactivity. Sacral neuromodulation and botulinum toxin A].
Amend B; Castro-Diaz D; Chartier-Kastler E; De Ridder D; Everaert K; Spinelli M; van Kereebroeck P; Sievert KD
Urologe A; 2010 Feb; 49(2):245-52. PubMed ID: 19859688
[TBL] [Abstract][Full Text] [Related]
7. Overactive Bladder.
White N; Iglesia CB
Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
[TBL] [Abstract][Full Text] [Related]
8. Management of refractory OAB in the non-neurogenic patient.
Wadie BS
Curr Urol Rep; 2014 Sep; 15(9):438. PubMed ID: 25015301
[TBL] [Abstract][Full Text] [Related]
9. New evidence in the treatment of overactive bladder.
Brown ET; Martin L; Dmochowski RR
Curr Opin Obstet Gynecol; 2015 Oct; 27(5):366-72. PubMed ID: 26308197
[TBL] [Abstract][Full Text] [Related]
10. Management of overactive bladder syndrome.
Srikrishna S; Robinson D; Cardozo L; Vella M
Postgrad Med J; 2007 Jul; 83(981):481-6. PubMed ID: 17621619
[TBL] [Abstract][Full Text] [Related]
11. [Overactive bladder-which treatment when?].
Pannek J
Urologe A; 2017 Dec; 56(12):1532-1538. PubMed ID: 29043374
[TBL] [Abstract][Full Text] [Related]
12. The evaluation and management of refractory neurogenic overactive bladder.
Kurpad R; Kennelly MJ
Curr Urol Rep; 2014 Oct; 15(10):444. PubMed ID: 25118853
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment of female overactive bladder syndrome and treatment-related effects.
Hsiao SM; Lin HH
J Formos Med Assoc; 2018 Oct; 117(10):871-878. PubMed ID: 29398096
[TBL] [Abstract][Full Text] [Related]
14. Re: Pathophysiology of Idiopathic Overactive Bladder and the Success of Treatment: A Systematic Review from ICI-RS 2013.
Wein AJ
J Urol; 2015 Aug; 194(2):474. PubMed ID: 26195388
[No Abstract] [Full Text] [Related]
15. The management of overactive bladder: percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin?
Tubaro A; Puccini F; De Nunzio C
Curr Opin Urol; 2015 Jul; 25(4):305-10. PubMed ID: 26049873
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Bywater M; Kessler TM
Praxis (Bern 1994); 2017; 106(21):1175-1181. PubMed ID: 29041854
[No Abstract] [Full Text] [Related]
17. Overactive bladder: diagnosis and management.
Robinson D; Cardozo L
Maturitas; 2012 Feb; 71(2):188-93. PubMed ID: 22197347
[TBL] [Abstract][Full Text] [Related]
18. Actual treatment of overactive bladder and urge urinary incontinence.
Cornu JN
Minerva Urol Nefrol; 2013 Mar; 65(1):21-35. PubMed ID: 23538308
[TBL] [Abstract][Full Text] [Related]
19. Urgency after a sling: review of the management.
Abraham N; Vasavada S
Curr Urol Rep; 2014 Apr; 15(4):400. PubMed ID: 24515329
[TBL] [Abstract][Full Text] [Related]
20. Improving Outcomes in Patients With Refractory Idiopathic and Neurogenic Detrusor Overactivity: Management Strategies.
Ginsberg DA; Schneider LK; Watanabe TK
Arch Phys Med Rehabil; 2015 Sep; 96(9 Suppl):S341-57.e1. PubMed ID: 26318392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
